Empirical Wealth Management’s Pacira BioSciences PCRX Stock Holding History

Empirical Wealth Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$600K	Sell	23,954 -459	-2%	-$11.6K	0.01%	699
2026 Q2	$619K	Buy	24,413 +2,154	+10%	+$50.9K	0.01%	591
2026 Q1	$503K	Buy	22,259 +6,944	+45%	+$154K	0.01%	569
2025 Q4	$396K	Buy	15,315 +2,358	+18%	+$56.1K	0.01%	596
2025 Q3	$334K	Buy	+12,957	New	+$318K	0.01%	582

Other funds holding PCRX

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return

Gagnon Advisors New York $182M AUM 52.04% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Empirical Wealth Management's PCRX Position: Q3 2026 in Review

Empirical Wealth Management reduced its Pacira BioSciences (PCRX) stake by 1.9% in Q3 2026, selling an estimated $11.6K and leaving 23,954 shares worth $600K. The position accounts for 0.01% of the portfolio, ranked #699.

Empirical Wealth Management first reported a position in PCRX in Q3 2025 and has held it in 5 quarters since. The position peaked at $619K in Q2 2026. 107 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.

Empirical Wealth Management held 23,954 shares of Pacira BioSciences worth $600K as of Q3 2026.
Empirical Wealth Management sold 459 Pacira BioSciences shares in Q3 2026, an estimated $11.6K.
Pacira BioSciences made up 0.01% of Empirical Wealth Management's portfolio in Q3 2026, its #699 holding.
Empirical Wealth Management first reported a position in Pacira BioSciences in Q3 2025 and has held it in 5 quarters since.
Empirical Wealth Management's Pacira BioSciences position peaked at $619K in Q2 2026.
107 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.

Based on Empirical Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.